Chattopadhyay C, Kim DW, Gombos DS, Oba J, Qin Y, Williams MD, Esmaeli B, Grimm EA, Wargo JA, Woodman SE, et al. Uveal melanoma: from diagnosis to treatment and the science in between. Cancer. 2016;122(15):2299–312.

Article  PubMed  Google Scholar 

Kaliki S, Shields CL. Uveal melanoma: relatively rare but deadly cancer. Eye (Lond). 2017;31(2):241–57.

Article  CAS  PubMed  Google Scholar 

Rusňák Š, Hecová L, Kasl Z, Sobotová M, Hauer L. Therapy of uveal melanoma a review. Ceska a slovenska oftalmologie: casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti. 2020;77(1):1–13.

PubMed  Google Scholar 

Kaliki S, Shields CL, Shields JA. Uveal melanoma: estimating prognosis. Indian J Ophthalmol. 2015;63(2):93–102.

Article  PubMed  PubMed Central  Google Scholar 

Carvajal RD, Schwartz GK, Tezel T, Marr B, Francis JH, Nathan PD. Metastatic disease from uveal melanoma: treatment options and future prospects. Br J Ophthalmol. 2017;101(1):38–44.

Article  PubMed  Google Scholar 

Schank TE, Hassel JC. Tebentafusp for the treatment of metastatic uveal melanoma. Future Oncol (London, England). 2022;18(11):1303–11.

Article  CAS  Google Scholar 

Spagnolo F, Caltabiano G, Queirolo P. Uveal melanoma. Cancer Treat Rev. 2012;38(5):549–53.

Article  PubMed  Google Scholar 

Bustamante P, Piquet L, Landreville S, Burnier JV. Uveal melanoma pathobiology: metastasis to the liver. Semin Cancer Biol. 2021;71:65–85.

Article  CAS  PubMed  Google Scholar 

Rossi E, Croce M, Reggiani F, Schinzari G, Ambrosio M, Gangemi R, Tortora G, Pfeffer U, Amaro A. Uveal melanoma metastasis. Cancers. 2021;13(22):5684.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaffal E. Research in practice: therapeutic targeting of oncogenic GNAQ mutations in uveal melanoma. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology: JDDG. 2020;18(11):1245–8.

PubMed  Google Scholar 

Silva-Rodríguez P, Fernández-Díaz D, Bande M, Pardo M, Loidi L, Blanco-Teijeiro MJ. GNAQ and GNA11 genes: a comprehensive review on oncogenesis, prognosis and therapeutic opportunities in uveal melanoma. Cancers. 2022;14(13):3066.

Article  PubMed  PubMed Central  Google Scholar 

Psinakis F, Katseli A, Koutsandrea C, Frangia K, Florentin L, Apostolopoulou D, Dimakopoulou K, Papakonstantinou D, Georgopoulou E, Brouzas D. Uveal melanoma: GNAQ and GNA11 mutations in a greek population. Anticancer Res. 2017;37(10):5719–26.

CAS  PubMed  Google Scholar 

Masoomian B, Shields JA, Shields CL. Overview of BAP1 cancer predisposition syndrome and the relationship to uveal melanoma. J Curr Ophthalmol. 2018;30(2):102–9.

Article  PubMed  PubMed Central  Google Scholar 

Djulbegovic MB, Taylor DJ, Uversky VN, Galor A, Shields CL, Karp CL. Intrinsic disorder in BAP1 and its association with uveal melanoma. Genes. 2022;13(10):1703.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smit KN, Jager MJ, de Klein A, Kiliҫ E. Uveal melanoma: towards a molecular understanding. Prog Retin Eye Res. 2020;75: 100800.

Article  PubMed  Google Scholar 

Laurent C, Valet F, Planque N, Silveri L, Maacha S, Anezo O, Hupe P, Plancher C, Reyes C, Albaud B, et al. High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients. Can Res. 2011;71(3):666–74.

Article  CAS  Google Scholar 

Worley LA, Onken MD, Person E, Robirds D, Branson J, Char DH, Perry A, Harbour JW. Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma. Clin Cancer Res: Off J Am Assoc Cancer Res. 2007;13(5):1466–71.

Article  CAS  Google Scholar 

van Essen TH, van Pelt SI, Bronkhorst IH, Versluis M, Némati F, Laurent C, Luyten GP, van Hall T, van den Elsen PJ, van der Velden PA, et al. Upregulation of HLA expression in primary uveal melanoma by infiltrating leukocytes. PLoS ONE. 2016;11(10): e0164292.

Article  PubMed  PubMed Central  Google Scholar 

Baqai U, Purwin TJ, Bechtel N, Chua V, Han A, Hartsough EJ, Kuznetsoff JN, Harbour JW, Aplin AE. Multi-omics profiling shows BAP1 loss is associated with upregulated cell adhesion molecules in uveal melanoma. Mol Cancer Res: MCR. 2022;20(8):1260–71.

Article  CAS  PubMed  Google Scholar 

Spagnolo F, Picasso V, Spano L, Tanda E, Venzano C, Queirolo P. Update on metastatic uveal melanoma: progress and challenges. BioDrugs: Clin Immunother Biopharm Gene Ther. 2016;30(3):161–72.

Article  CAS  Google Scholar 

Woodman SE. Metastatic uveal melanoma: biology and emerging treatments. Cancer journal (Sudbury, Mass). 2012;18(2):148–52.

Article  CAS  PubMed  Google Scholar 

Schaller UC, Bosserhoff AK, Neubauer AS, Buettner R, Kampik A, Mueller AJ. Melanoma inhibitory activity: a novel serum marker for uveal melanoma. Melanoma Res. 2002;12(6):593–9.

Article  CAS  PubMed  Google Scholar 

Reiniger IW, Wolf A, Welge-Lüssen U, Mueller AJ, Kampik A, Schaller UC. Osteopontin as a serologic marker for metastatic uveal melanoma: results of a pilot study. Am J Ophthalmol. 2007;143(4):705–7.

Article  CAS  PubMed  Google Scholar 

Riechardt AI, Kilic E, Joussen AM. The genetics of uveal melanoma: overview and clinical relevance. Klin Monatsbl Augenheilkd. 2021;238(7):773–80.

Article  PubMed  Google Scholar 

Seider MI, Mruthyunjaya P. Molecular prognostics for uveal melanoma. Retina (Philadelphia, Pa). 2018;38(2):211–9.

Article  PubMed  Google Scholar 

Caines R, Eleuteri A, Kalirai H, Fisher AC, Heimann H, Damato BE, Coupland SE, Taktak AF. Cluster analysis of multiplex ligation-dependent probe amplification data in choroidal melanoma. Mol Vis. 2015;21:1–11.

CAS  PubMed  PubMed Central  Google Scholar 

Musi E, Ambrosini G, de Stanchina E, Schwartz GK. The phosphoinositide 3-kinase α selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells. Mol Cancer Ther. 2014;13(5):1044–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blankman JL, Simon GM, Cravatt BF. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol. 2007;14(12):1347–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chicca A, Nicolussi S, Bartholomäus R, Blunder M, Aparisi Rey A, Petrucci V, Reynoso-Moreno IDC, Viveros-Paredes JM, Dalghi Gens M, Lutz B, et al. Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake. Proc Natl Acad Sci USA. 2017;114(25):E5006-e5015.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma X, Xia M, Wei L, Guo K, Sun R, Liu Y, Qiu C, Jiang J. ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL. Cell Death Dis. 2022;13(12):1067.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li CF, Chuang IC, Liu TT, Chen KC, Chen YY, Fang FM, Li SH, Chen TJ, Yu SC, Lan J, et al. Transcriptomic reappraisal identifies MGLL overexpression as an unfavorable prognosticator in primary gastrointestinal stromal tumors. Oncotarget. 2016;7(31):49986–97.

Article  PubMed  PubMed Central  Google Scholar 

Nomura DK, Long JZ, Niessen S, Hoover HS, Ng SW, Cravatt BF. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell. 2010;140(1):49–61.

Article